These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 16737940

  • 1. Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.
    Yüksel M, Baron E, Camouse M, Cooper BW, Lazarus HM, Gerson SL, Laughlin MJ, Cooper KD, Gilliam A, Fu P, Stevens S, Koç ON.
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):665-71. PubMed ID: 16737940
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [Abstract] [Full Text] [Related]

  • 4. Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
    Rabitsch W, Reiter E, Keil F, Malzer R, Leitner G, Fischer G, Dieckman K, Kalhs P, Lechner K, Greinix HT.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S49-52. PubMed ID: 9916635
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
    Urbano-Ispizua A, Solano C, Brunet S, de la Rubia J, Odriozola J, Zuazu J, Figuera A, Caballero D, Martínez C, García J, Sanz G, Torrabadella M, Alegre A, Pérez-Oteiza J, Jurado M, Oyonarte S, Sierra J, García-Conde J, Rozman C.
    Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
    [Abstract] [Full Text] [Related]

  • 6. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L.
    Blood Cells Mol Dis; 2008 Sep; 40(1):13-9. PubMed ID: 17869547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin.
    Lamparelli T, van Lint MT, Gualandi F, Raiola AM, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Bregante S, Berisso G, Dominietto A, Di Grazia C, Bruno B, Sessarego M, Casarino L, Verdiani S, Bacigalupo A.
    Bone Marrow Transplant; 2000 Dec; 26(12):1305-11. PubMed ID: 11223970
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P, Da Prada GA, Giorgiani G, Schiavo R, Zambelli A, Giraldi E, Landonio G, Locatelli F, Siena S, Della Cuna GR.
    Cancer; 2002 May 01; 94(9):2409-15. PubMed ID: 12015766
    [Abstract] [Full Text] [Related]

  • 10. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
    Sobecks RM, Daugherty CK, Hallahan DE, Laport GF, Wagner ND, Larson RA.
    Bone Marrow Transplant; 2000 Apr 01; 25(8):807-13. PubMed ID: 10808200
    [Abstract] [Full Text] [Related]

  • 11. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
    Cutler C, Kim HT, Hochberg E, Ho V, Alyea E, Lee SJ, Fisher DC, Miklos D, Levin J, Sonis S, Soiffer RJ, Antin JH.
    Biol Blood Marrow Transplant; 2004 May 01; 10(5):328-36. PubMed ID: 15111932
    [Abstract] [Full Text] [Related]

  • 12. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A.
    Biol Blood Marrow Transplant; 2005 May 01; 11(5):389-98. PubMed ID: 15846293
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
    Bethge WA, Haegele M, Faul C, Lang P, Schumm M, Bornhauser M, Handgretinger R, Kanz L.
    Exp Hematol; 2006 Dec 01; 34(12):1746-52. PubMed ID: 17157172
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation.
    Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Moussa E, Karaoui M, Roberts G, El-Solh H.
    Bone Marrow Transplant; 2004 Jan 01; 33(1):15-7. PubMed ID: 14578932
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
    van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M, Maynard V, Stock W, Peace D, Ravandi F, Chen YH, Cheung T, Vijayakumar S, Hoffman R, Sosman J.
    Bone Marrow Transplant; 2003 Jul 01; 32(1):9-13. PubMed ID: 12815472
    [Abstract] [Full Text] [Related]

  • 18. Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine.
    Görner M, Kordelas L, Thalheimer M, Luft T, Pfeiffer S, Ustaoglu F, Punzel M, Weber-Nordt R, Moos M, Goldschmidt H, Ho AD.
    Bone Marrow Transplant; 2002 Apr 01; 29(7):621-4. PubMed ID: 11979314
    [Abstract] [Full Text] [Related]

  • 19. [Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].
    Petersen EJ, Lokhorst HL, Verdonck LF.
    Ned Tijdschr Geneeskd; 2003 Nov 22; 147(47):2328-32. PubMed ID: 14669540
    [Abstract] [Full Text] [Related]

  • 20. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.
    Hartwig UF, Winkelmann N, Wehler T, Kreiter S, Schneider PM, Meyer RG, Ullmann AJ, Huber C, Kolbe K, Herr W.
    Ann Hematol; 2005 May 22; 84(5):331-8. PubMed ID: 15726363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.